Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Sinclair

Showing results (181-190 of 256) with videos related to

Pageof 26
Sort By:
Experimental Dermatology|June 28, 2023
Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomised, double-blind, placebo-controlled Phase Ib studyRodney Sinclair, Sammy Sharifeh, Susan Thackwray, et al.
Stem Cells and Development|December 23, 2011
Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissueSarah Tzu-Feng Hsiao, Azar Asgari, Zerina Lokmic, et al.
Dermatologic Therapy|October 7, 2016
Prevalence of hair shedding among womenMaja Kovacevic, Andy Goren, Jerry Shapiro, et al.
Journal of the American Academy of Dermatology|March 4, 2022
Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patientsMatilde Iorizzo, Michela Starace, Sergio Vano-Galvan, et al.
Journal of the American Academy of Dermatology|December 16, 2021
Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trialElena Peeva, Emma Guttman-Yassky, Anindita Banerjee, et al.
International Journal of Dermatology|October 10, 2025
Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3Ernest H Law, Bintu Sherif, Arash Mostaghimi, et al.
The Australasian Journal of Dermatology|May 3, 2025
Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in AustraliaRodney Sinclair, Samantha Eisman, Carol M Y Lee, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 4, 2006
Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trialWolfram Sterry, Georg Stingl, Richard G B Langley, et al.
Clinical and Experimental Dermatology|January 25, 2024
Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinibGia Toan Tang, Daranporn Triwongwaranat, Rodney Sinclair, et al.
Dermatology and Therapy|September 5, 2023
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical StudyChristopher John Wynne, Alexandra Cole, Charlotte Lemech, et al.
Pageof 26

Showing results (181-190 of 256) with videos related to

Sort By:
Pageof 26
Experimental Dermatology|June 28, 2023
Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomised, double-blind, placebo-controlled Phase Ib studyRodney Sinclair, Sammy Sharifeh, Susan Thackwray, et al.
Stem Cells and Development|December 23, 2011
Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissueSarah Tzu-Feng Hsiao, Azar Asgari, Zerina Lokmic, et al.
Dermatologic Therapy|October 7, 2016
Prevalence of hair shedding among womenMaja Kovacevic, Andy Goren, Jerry Shapiro, et al.
Journal of the American Academy of Dermatology|March 4, 2022
Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patientsMatilde Iorizzo, Michela Starace, Sergio Vano-Galvan, et al.
Journal of the American Academy of Dermatology|December 16, 2021
Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trialElena Peeva, Emma Guttman-Yassky, Anindita Banerjee, et al.
International Journal of Dermatology|October 10, 2025
Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3Ernest H Law, Bintu Sherif, Arash Mostaghimi, et al.
The Australasian Journal of Dermatology|May 3, 2025
Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in AustraliaRodney Sinclair, Samantha Eisman, Carol M Y Lee, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 4, 2006
Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trialWolfram Sterry, Georg Stingl, Richard G B Langley, et al.
Clinical and Experimental Dermatology|January 25, 2024
Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinibGia Toan Tang, Daranporn Triwongwaranat, Rodney Sinclair, et al.
Dermatology and Therapy|September 5, 2023
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical StudyChristopher John Wynne, Alexandra Cole, Charlotte Lemech, et al.
Pageof 26